Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Your voice may reveal hidden depression: new study tests speech screening

NCT ID NCT07578155

Diagnosis Sponsor: Accexible Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a speech analysis platform called AcceXible can accurately screen for depression and anxiety in university students. Over 900 students aged 16-25 provided voice samples through open-ended speaking tasks. The platform analyzed acoustic and linguistic features to see if it could identify those with depression or anxiety, compared to standard questionnaires. The goal is to develop a quick, digital screening tool that could help catch mental health issues earlier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AcceXible speech analysis platform
What this could lead to
If successful, this could provide a quick, non-invasive way to screen for depression and anxiety using just a voice recording.
What could go wrong
This is a validation study, not a treatment trial. The technology may not be accurate enough for real-world use, and results may not apply beyond the student population tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

902 people

The number who actually took part.

Started

Mar 2024

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

University students enrolled at the Universidad Autónoma de Coahuila (UAdeC)

Ages

16 to 25 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Provision of voluntary written informed consent * Age 16-25 years * Current enrollment at BUAP * Spanish language proficiency * Access to a mobile device with internet connectivity * Ability to understand and follow basic acceXible usage instructions Exclusion Criteria: * Refusal to participate * Psychomotor agitation * Sensory impairment (visual or auditory)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Depression - major depressive disorder

Contacts and locations

Locations

  • Universidad Autónoma de Coahuila (UAdeC)

    Saltillo, Coahuila, 25280, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.